WESTON, Fla., July 30, 2019 /PRNewswire/ -- Cleveland Clinic Florida has maintained  the top spot as the No. 1 hospital in the Miami-Fort Lauderdale metro area for 2019-2020, according to the newly released annual ranking of Best Hospitals by U.S. News & World Report. The annual

HANOVER, Md., July 30, 2019 /PRNewswire/ -- Aerotek, Inc., a leading provider of recruiting and staffing services, announced today that it has been recognized by 

BEDFORD, N.H., July 30, 2019 /PRNewswire/ -- Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization, continues their expansion with the addition of increased cGMP storage capabilities at its 7 Commerce Drive facility located in Bedford, New Hampshire. This new space is

OKLAHOMA CITY, July 30, 2019 /PRNewswire/ -- Energy & Environmental Services, Inc. (OTC: EESE) today announced that it has received certification from the Environmental Protection Agency to produce registered biocides at its plant in Edmond, Oklahoma. The manufacturing, creation, and production of biocides are regulated by the EPA. Th

BOULDER, Colo., July 30, 2019 /PRNewswire/ -- Amplifire is pleased to announce that Brent James, MD, MStat, will serve as Chairman of the Amplifire Healthcare Alliance Clinical Innovation Advisory Board. Dr. James has long been recognized internationally for his work in clinical quality improvement, patient safety and the infrastructur

CLEARWATER, Fla., July 30, 2019 /PRNewswire/ -- Excell Biotech LLC, a startup biotechnology company developing vaccines and gene therapies for viral infections and auto immune diseases, announced that it has developed a vaccine for the Herpes Simplex virus. The EXD-12 vaccine is a live attenuated virus vaccine. Although still in the development phase there is a lot of op

SAN CARLOS, Calif., July 30, 2019 /PRNewswire/ -- LakePharma, Inc., the leading US-based biologics CRDMO, announced the theme for its 2019 annual symposium: Next-Generation Therapeutics. The symposium will feature presentations by distinguished guest speakers on the latest advances in innovative technologies that are helping to bring about the next generation of the

PLYMOUTH MEETING, Pa., July 30, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that second quarter 2019 financial results will be released after the market close on August 8, 2019. Following the release, the company will host a conference call and live webcast at 4:30 p.m. ET

LOS ANGELES, July 30, 2019 /PRNewswire/ -- CytRx Corporation (OTCQB: CYTR), a biopharmaceutical research and development company specializing in oncology and rare diseases, today highlighted that following a positive meeting with the U.S. Food and Drug Administration (FDA), arimoclomol licensee Orphazyme A/S (ORPH.CO) remains on track to submit a New Drug Applicatio

SAN DIEGO, July 30, 2019 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) will hold a conference call to discuss financial results and business highlights for the second quarter ended June 30, 2019, as follows: